Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
11 studies found for:    Hypersensitivity Pneumonitis | Open Studies | NIH, U.S. Fed
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting New Techniques for Using a Saline Wash as a Diagnostic Tool for Pneumocystis Pneumonia
Condition: Pneumocystis Infection
Intervention:
2 Recruiting Aerosolized and Intravenous Colistin in Healthy Adults
Conditions: Pathogen Resistance;   Pneumococcal Infection;   Pneumonia
Intervention: Drug: Colistimethate sodium
3 Unknown  Observational Study of Sepsis and Pneumonia to Develop Diagnostic Tests
Conditions: Sepsis;   Septicemia;   Sepsis Syndrome;   Shock, Septic;   Community Acquired Pneumonia
Intervention:
4 Recruiting Study of Clinical Features and Genetics of Hyperimmunoglobulin E Recurrent Infection
Condition: Job's Syndrome
Intervention:
5 Recruiting Mechanisms of Impaired HIV-associated B Cell and Pneumococcal Vaccine Responses
Conditions: HIV;   Pneumococcal Infections;   Pneumococcal Vaccines
Interventions: Biological: PCV-13;   Biological: PPSV-23
6 Recruiting Evaluating the Safety and Efficacy of Anti-Influenza Intravenous Hyperimmune Immunoglobulin (IVIG) in Adults Hospitalized With Influenza
Conditions: Influenza A;   Influenza B
Interventions: Biological: Intravenous hyperimmune immunoglobulin (IVIG);   Biological: Placebo for IVIG
7 Recruiting Evaluating the Use of Oseltamivir for the Treatment of Influenza in Adults
Condition: Influenza, Human
Interventions: Drug: Oseltamivir;   Drug: Oseltamivir Placebo
8 Recruiting Multiplex Microarray Chip-Based Diagnosis of Respiratory Infections
Condition: HIV
Intervention:
9 Recruiting Study of Effectiveness and Safety of Azithromycin-based Extended-spectrum Prophylaxis to Prevent Post Cesarean Infection
Conditions: Endometritis;   Wound Infection;   Abscess;   Surgical Site Infection
Interventions: Drug: Azithromycin;   Drug: Placebo
10 Recruiting Evaluating the Safety, Effectiveness, and Tolerability of Nitazoxanide in Addition to Standard Care for the Treatment of Severe Acute Respiratory Illness in People Who Are Hospitalized
Condition: Severe Acute Respiratory Illness
Interventions: Drug: Nitazoxanide (NTZ);   Drug: Placebo
11 Recruiting Evaluating the Safety and Immune Response to a Respiratory Syncytial Virus (RSV) Vaccine in Adults, RSV-Seropositive Children, and RSV-Seronegative Infants and Children
Condition: Respiratory Syncytial Virus Infections
Interventions: Biological: RSV MEDI ΔM2-2 vaccine;   Biological: Placebo vaccine

Indicates status has not been verified in more than two years